Rifapentine
Active substance: rifapentine
TABLET, FILM COATED · RIFAPENTINE 150 mg/1
United StatesActive
Marketing holder: Macleods Pharmaceuticals Limited
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- RIFAPENTINE · 150 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208e-04f7-76c4-b6a4-a9772acc6082,01a1209d-1c97-742b-88a5-fd26b0f95f93;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 33342-599
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 33342-599 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 33342-599 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 33342-599 · Verified 2026-10-09 · open in source